|
|
|
|
|
by Beefin
2353 days ago
|
|
That makes zero sense, the effort is in deriving insights in producing something tangible - drugs. That's like saying you want a cut from all of Google's revenue because you use their search engine, or you want a cut from any service because they use the analytics from your use to improve their product. |
|
In Google and everyone else's case, I would argue it's a bit different. Google remunerates me with the best search engine in the world, excellent free email, etc. Other services improve the product, which I (generally) reap the benefits of.
On the other hand, your genetics are what they are -- I don't believe 23andMe is sending every participant a coupon for this new drug, although I might be wrong. Instead, all you get is a small sample of the 600k SNPs available, some shaky genetic inferences, and tabloid level ethnic data. You give up valuable data with huge upside for analysis of questionable integrity and limited actionability.